David A Roth

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Venues

RMD open

Arthritis & rheumatology (Hoboken, N.J.)

Clinical journal of the American Society of Nephrology : CJASN

Temple University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Temple University Jul 1o 1994 - Aug 30o 1997

United States

Assistant Professor of Medicine :: Nephrology

Publications

Richard A Furie, Brad H Rovin, Frédéric Houssiau, Gabriel Contreras, Y K Onno Teng, Paula Curtis, Yulia Green, Mohamed Okily, Anuradha Madan, David A Roth
Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN Study. Clinical journal of the American Society of Nephrology : CJASN 17 (11) (2022)
Fengchun Zhang, Jie Zheng, Yang Li, Guochun Wang, Mingjun Wang, Yin Su, Jieruo Gu, Xingfu Li, Damon L Bass, Myron Chu, Paula Curtis, Kathleen DeRose, Regina Kurrasch, Jenny Lowe, Paige Meizlik, David A Roth
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years. RMD open 8 (1) (2022)
Hermine I Brunner, Carlos Abud Mendoza, Masaaki Mori, Clarissa A Pilkington, Reema Syed, Syuji Takei, Diego O Viola, Richard A Furie, Sandra V Navarra, Fengchun Zhang, Damon L Bass, Gina Eriksson, Anne E Hammer, Beulah N Ji, Mohamed Okily, David A Roth, Holly A Quasny, Nicolino Ruperto
Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison. RMD open 7 (3) (2021)
Yoshiya Tanaka, Sang-Cheol Bae, Damon L Bass, Paula Curtis, Myron Chu, Kathleen DeRose, Beulah N Ji, Regina Kurrasch, Jenny Lowe, Paige Meizlik, David A Roth
Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea. RMD open 7 (2) (2021)
Daniel J Wallace, Ellen M Ginzler, Joan T Merrill, Richard A Furie, William Stohl, W Winn Chatham, Arthur Weinstein, James D McKay, W Joseph McCune, Michelle A Petri, James Fettiplace, David A Roth, Beulah N Ji, Amy Heath
Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus. Arthritis & rheumatology (Hoboken, N.J.) 71 (7) (2019)

David A Roth.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David A Roth